Mwanzo069620 • KRX
add
Daewoong Pharma
Bei iliyotangulia
₩ 154,600.00
Bei za siku
₩ 154,600.00 - ₩ 161,600.00
Bei za mwaka
₩ 100,100.00 - ₩ 171,600.00
Thamani ya kampuni katika soko
1.83T KRW
Wastani wa hisa zilizouzwa
elfu 44.43
Uwiano wa bei na mapato
47.27
Mgao wa faida
0.38%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 356.49B | 6.17% |
Matumizi ya uendeshaji wa biashara | 144.21B | 2.17% |
Mapato halisi | 21.89B | 168.81% |
Kiwango cha faida halisi | 6.14 | 152.67% |
Mapato kwa kila hisa | — | — |
EBITDA | 50.94B | 23.00% |
Asilimia ya kodi ya mapato | 20.03% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 102.86B | -19.04% |
Jumla ya mali | 1.99T | 9.98% |
Jumla ya dhima | 1.06T | 20.84% |
Jumla ya hisa | 929.54B | — |
hisa zilizosalia | 11.51M | — |
Uwiano wa bei na thamani | 2.21 | — |
Faida inayotokana na mali | 4.88% | — |
Faida inayotokana mtaji | 5.97% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 21.89B | 168.81% |
Pesa kutokana na shughuli | 3.08B | -80.79% |
Pesa kutokana na uwekezaji | -21.95B | 62.15% |
Pesa kutokana na ufadhili | 13.82B | -60.73% |
Mabadiliko halisi ya pesa taslimu | -5.17B | 9.92% |
Mtiririko huru wa pesa | -24.56B | 41.58% |
Kuhusu
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1945
Tovuti
Wafanyakazi
1,727